Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Indian J Pediatr ; 2009 Sept; 76(9): 950-951
Artigo em Inglês | IMSEAR | ID: sea-142378

RESUMO

Functional follicular ovarian cysts are frequently reported in girls with peripheral precocious puberty (PP). These cysts are usually self-limiting and resolve spontaneously. Several drugs like antiestrogens (tamoxifen) and new aromatase inhibitors are seldom used for treatment. Here we report a girl with peripheral PP who presented with unilateral enlargement of the ovary and a recurrent autonomous ovarian cyst. No skin pigmentation or bone anomaly was noted. The patient was successfully treated with anastrozole, a highly selective aromatase inhibitor. No adverse reaction was noted. Anastrozole is a safe and tolerable drug especially used to suppress estrogen action.


Assuntos
Inibidores da Aromatase/uso terapêutico , Criança , Feminino , Humanos , Nitrilas/uso terapêutico , Cistos Ovarianos/tratamento farmacológico , Puberdade Precoce/tratamento farmacológico , Recidiva , Triazóis/uso terapêutico
2.
Indian J Pediatr ; 2008 Feb; 75(2): 186-8
Artigo em Inglês | IMSEAR | ID: sea-80355

RESUMO

We report a 3-month-old male with infantile hypophosphatasia who later developed Pseudotumor cerebri. At the age of 3 months, he was referred to our hospital because of pneumonia and respiratory insufficiency. He had short extremities, and radiographs of the bones were consistent with lack of metaphyseal mineralization and bowed lower extremities. Vomiting and bulging fontanelle developed 3 months after admission, and CSF opening pressure was notably high at 430 mm/H2O. Hypophosphatasia is a very rare cause of pseudotumor cerebri. This report is the first case where PTC is associated with hypophosphatasia and responded well to corticosteroid therapy.


Assuntos
Corticosteroides/uso terapêutico , Humanos , Hipofosfatasia/complicações , Lactente , Masculino , Pseudotumor Cerebral/complicações , Insuficiência Respiratória/complicações , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA